B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function? is a research paper published in Science Translational Medicine (2022). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →CIHR
Grant: 433117
NCI NIH HHS
Grant: U01 CA243072
NCI NIH HHS
Grant: U2C CA233285
NCI NIH HHS
Grant: U01 CA232361
National Institutes of Health
Grant: 5U01CA243072-05
Towards rational design of combination therapeutic targets
National Institutes of Health
Grant: 1U01CA232361-01A1
Defining and overcoming intrinsic T cell dysfunction to enable pediatric immunotherapy
Canadian Institutes of Health Research
Grant: unidentified
unidentified
European Commission
Grant: 233285
Discovery of Type 2 Diabetes Targets
National Institutes of Health
Grant: 5U2CCA233285-02
Center for pediatric tumor cell atlas
FWCI
1.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals